Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression

BACKGROUND: Cardiogenic shock complicates 5–10% of myocardial infarction (MI) cases. Data about the benefit of glycoprotein IIb/IIIa inhibitors (GPI) in these patients is sparse and conflicting. METHODS: We performed a systematic review, meta-analysis, and meta-regression of studies assessing the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleiro, Carolina, Teixeira, Rogério, De Campos, Diana, Lopes, João, Oliveiros, Bárbara, Costa, Marco, Gonçalves, Lino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656750/
https://www.ncbi.nlm.nih.gov/pubmed/33292610
http://dx.doi.org/10.1186/s40560-020-00502-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656750/
https://www.ncbi.nlm.nih.gov/pubmed/33292610
http://dx.doi.org/10.1186/s40560-020-00502-y

Ejemplares similares